Is Agilon Health (AGL) Stock Outpacing Its Medical Peers This Year?

Zacks
03-20

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Agilon Health (AGL) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out.

Agilon Health is a member of the Medical sector. This group includes 1012 individual stocks and currently holds a Zacks Sector Rank of #4. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.

The Zacks Rank is a proven model that highlights a variety of stocks with the right characteristics to outperform the market over the next one to three months. The system emphasizes earnings estimate revisions and favors companies with improving earnings outlooks. Agilon Health is currently sporting a Zacks Rank of #2 (Buy).

The Zacks Consensus Estimate for AGL's full-year earnings has moved 21.3% higher within the past quarter. This shows that analyst sentiment has improved and the company's earnings outlook is stronger.

Based on the most recent data, AGL has returned 131.6% so far this year. Meanwhile, the Medical sector has returned an average of 4.9% on a year-to-date basis. This means that Agilon Health is performing better than its sector in terms of year-to-date returns.

Another Medical stock, which has outperformed the sector so far this year, is Paragon 28, Inc. (FNA). The stock has returned 26.1% year-to-date.

For Paragon 28, Inc. the consensus EPS estimate for the current year has increased 3.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).

Looking more specifically, Agilon Health belongs to the Medical Services industry, which includes 59 individual stocks and currently sits at #63 in the Zacks Industry Rank. Stocks in this group have gained about 5.6% so far this year, so AGL is performing better this group in terms of year-to-date returns.

Paragon 28, Inc. however, belongs to the Medical - Instruments industry. Currently, this 84-stock industry is ranked #81. The industry has moved -3.1% so far this year.

Investors with an interest in Medical stocks should continue to track Agilon Health and Paragon 28, Inc. These stocks will be looking to continue their solid performance.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Agilon Health, Inc. (AGL) : Free Stock Analysis Report

Paragon 28, Inc. (FNA) : Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10